LRPPRC and idiopathic pulmonary fibrosis: In addition, we identified two novel prognostic m6A regulators (LRPPRC and FTO) in IPF for the first time and obtained a total of 100 compounds or natural products as potential drugs targeting LRPPRC and FTO in the treatment of IPF with the aid of virtual screening technology.